HMG-CoA 还原酶 (HMGCR) 是胆固醇合成的限速酶,在将 HMG-CoA 转化为甲羟戊酸的过程中起着决定作用。HMGCR 存在于真核生物和原核生物中。系统发育分析揭示了两类 HMG-CoA 还原酶,真核生物和一些古细菌的 I 类酶以及真细菌和某些其他古细菌的 II 类酶。
已知在真核生物和古细菌中,HMGCR 酶可催化异戊二烯生物合成特有的早期反应。在人类中,HMG-CoA 还原酶反应是胆固醇生物合成的限速酶,因此是降低血清胆固醇水平药物的主要靶标。
HMG-CoA Reductase (HMGCR) is the rate-limiting enzyme for cholesterol synthesis in the conversion of HMG-CoA to mevalonate. HMGCR is found in eukaryotes and prokaryotes. The phylogenetic analysis has revealed two classes of HMG-CoA reductase, the Class I enzymes of eukaryotes and some archaea and the Class II enzymes of eubacteria and certain other archaea.
Both in eukaryotes and in archaebacteria the enzyme HMGCR is known to catalyze an early reaction unique to isoprenoid biosynthesis. In humans, the HMG-CoA reductase reaction is rate-limiting for the biosynthesis of cholesterol and therefore constitutes a prime target of drugs that reduce serum cholesterol levels.
PROTAC HMGCR Degrader-1 是一种口服活性的 HMGCR PROTAC 降解剂(IC50 为 1.32 μM),也是一种由 PROTAC HMGCR Degrader-2 (MS-G30811) 衍生而来的内酯前药,其在体内可实现活性成分的高血浆暴露,导致强效的 HMGCR 降解,并显示出良好的降胆固醇功效,可用于高血脂症的相关研究。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号